Abstract:Highlights • Inspired by equipping normal cells with radioprotective armor, a DNA tetrahedron-based nanosuit was formed by co-incubation of three-dimensional polyhedron tetrahedral framework nucleic acids and amifostine. • The nanosuit exhibited excellent ability to selectively shield normal tissues from irradiation-induced DNA damage. • The nanosuit could reduce irradiation-induced pathological damages of multi-organ. • The nanosuit showed robust protection of mice from lethal radiation. Unnecessary exposure to ionizing radiation (IR) often causes acute and chronic oxidative damages to normal cells and organs, leading to serious physiological and even life-threatening consequences. Amifostine (AMF) is a validated radioprotectant extensively applied in radiation and chemotherapy medicine, but the short half-life limits its bioavailability and clinical applications, remaining as a great challenge to be addressed. DNA-assembled nanostructures especially the tetrahedral framework nucleic acids (tFNAs) are promising nanocarriers with preeminent biosafety, low biotoxicity, and high transport efficiency. The tFNAs also have a relative long-term maintenance for structural stability and excellent endocytosis capacity. We therefore synthesized a tFNA-based delivery system of AMF for multi-organ radioprotection (tFNAs@AMF, also termed nanosuit). By establishing the mice models of accidental total body irradiation (TBI) and radiotherapy model of Lewis lung cancer, we demonstrated that the nanosuit could shield normal cells from IR-induced DNA damage by regulating the molecular biomarkers of anti-apoptosis and anti-oxidative stress. In the accidental total body irradiation (TBI) mice model, the nanosuit pretreated mice exhibited satisfactory alteration of superoxide dismutase (SOD) activities and malondialdehyde (MDA) contents, and functional recovery of hematopoietic system, reducing IR-induced pathological damages of multi-organ and safeguarding mice from lethal radiation. More importantly, the nanosuit showed a selective radioprotection of the normal organs without interferences of tumor control in the radiotherapy model of Lewis lung cancer. Based on a conveniently available DNA tetrahedron-based nanocarrier, this work presents a high-efficiency delivery system of AMF with the prolonged half-life and enhanced radioprotection for multi-organs. Such nanosuit pioneers a promising strategy with great clinical translation potential for radioactivity protection. Graphical abstract Download : Download high-res image (348KB) Download : Download full-size image

Selective Organ‐Targeting Hafnium Oxide Nanoparticles with Multienzyme‐Mimetic Activities Attenuate Radiation‐Induced Tissue Damage (Adv. Mater. 19/2024)

X‐ray Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy

Biodegradable hafnium-doped CaCO3 nanoparticles as a dual-modality radiosensitizer for cancer radiotherapy

Oxygen‐Enriched Metal‐Phenolic X‐Ray Nanoprocessor for Cancer Radio‐Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy

Engineering biomimetic nanosystem targeting multiple tumor radioresistance hallmarks for enhanced radiotherapy

Gram-scale Synthesis of Highly Biocompatible and Intravenous Injectable Hafnium Oxide Nanocrystal with Enhanced Radiotherapy Efficacy for Cancer Theranostic.

Hafnium oxide nanoparticles coated ATR inhibitor to enhance the radiotherapy and potentiate antitumor immune response

Hafnium (Hf)-Chelating Porphyrin-Decorated Gold Nanosensitizers for Enhanced Radio-Radiodynamic Therapy of Colon Carcinoma

Harnessing Hafnium‐Based Nanomaterials for Cancer Diagnosis and Therapy (Small 32/2023)

Full-ProcessRadiosensitization Based on NanoscaleMetal–Organic Frameworks

Stimuli-Responsive Small-on-Large Nanoradiosensitizer for Enhanced Tumor Penetration and Radiotherapy Sensitization

Manipulating Radiation‐Sensitive Z‐DNA Conformation for Enhanced Radiotherapy

Tantalum-carbon-integrated nanozymes as a nano-radiosensitizer for radiotherapy enhancement

A DNA tetrahedron-based nanosuit for efficient delivery of amifostine and multi-organ radioprotection

Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition Via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects.

NIR-II Light-Assisted Radiotherapy Based on Ultrasmall HfO2-embedded Porous Carbon Nanooctahedra for Overcoming Tumor Radioresistance

Cellular fate and performance of group IV metal organic framework radioenhancers

High-throughput Preparation of Radioprotective Polymers Via Hantzsch’s Reaction for in Vivo X-ray Damage Determination

Ultrafast Fabrication of Iron/Manganese Co-Doped Bismuth Trimetallic Nanoparticles: A Thermally Aided Chemodynamic/Radio-Nanoplatform for Low-Dose Radioresistance.

A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation

Catalytically Active Ti‐Based Nanomaterials for Hydroxyl Radical Mediated Clinical X‐Ray Enhancement